Replenine®-VF (High Purity Factor IX)
Sponsors
Bio Products Laboratory
Conditions
Haemophilia B
Phase 3
An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients
CompletedNCT02231944
Start: 1997-07-31Updated: 2018-02-22
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.
CompletedNCT02250560
Start: 2000-04-30Updated: 2018-02-22
An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery
CompletedNCT02250573
Start: 2005-12-31Updated: 2018-02-22
A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B
CompletedNCT02263456
Start: 1997-07-31Updated: 2014-10-13
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years
CompletedNCT02263469
Start: 2005-08-31Updated: 2014-10-13